When was Spinraza approved by the FDA?

by Marta Figueiredo, PhD | April 10, 2023

When was Spinraza approved by the FDA?

Category: Spinraza

The U.S. Food and Drug Administration (FDA) approved Spinraza for the treatment of spinal muscular atrophy (SMA) in 2016. This was a landmark approval, as no other disease-modifying therapies that could target the underlying cause of SMA had been approved at the time.

Print This Page

About the Author

Marta Figueiredo, PhD Marta holds a biology degree, a master’s in evolutionary and developmental biology, and a PhD in biomedical sciences from the University of Lisbon, Portugal. She was awarded a research scholarship and a PhD scholarship, and her research focused on the role of several signaling pathways in thymus and parathyroid glands embryonic development. She also previously worked as an assistant professor of an annual one-week embryology course at the University of Lisbon’s Faculty of Medicine.